Authors


Ming-Yu Fan, PhD

Latest:

Long-term Cost Effects of Collaborative Care for Late-life Depression

Older adults with depression and comorbidities who participated in a 12-month collaborative care program had lower total healthcare costs over 4 years than those in care as usual.


Annette L. Adams, PhD, MPH

Latest:

Trends in Bisphosphonate Initiation Within an Integrated Healthcare Delivery System

The authors observed a marked shift toward treatment of higher-risk subsets of younger postmenopausal women (with prior fracture and/or with osteoporosis), and away from women at lower risk.






Victor J. Stevens, PhD

Latest:

Documentation of the 5 As for Smoking Cessation by PCPs Across Distinct Health Systems

Evaluation of the 5 As of smoking cessation using patient electronic medical records across 6 distinct healthcare systems, stratified by comorbidity, gender, age, race ethnicity.



Albert Chan, MD, MS

Latest:

Nudging Physicians and Patients With Autopend Clinical Decision Support to Improve Diabetes Management

Incorporating an autopend functionality into clinical decision support improved glycated hemoglobin laboratory test completion by between 21.1% and 33.9% for reminder messages read within 57 days.


Christopher Lau, PhD

Latest:

How Will Provider-Focused Payment Reform Impact Geographic Variation in Medicare Spending?

Unlike ACOs or P4P, implementation of bundled payment for inpatient and post acute care in Medicare would modestly reduce geographic variation in spending.


Aimee Zapata, MS

Latest:

Patient Ratings of Veterans Affairs and Affiliated Hospitals

The mean online patient rating for Veterans Affairs hospitals was higher (3.70 ± 1.3 out of 5) than the rating for affiliated hospitals (3.19 ± 1.3; P = .003).


Xiao Xiang, PhD

Latest:

Is Higher Patient Satisfaction Associated With Better Stroke Outcomes?

Global patient satisfaction was positively associated with quality of stroke care and higher discharge information satisfaction may be linked to worse outcomes. Additionally, improvements in satisfactions were linked to higher costs.



Hena N. Patel, MD

Latest:

Diabetes: An Opportunity to Have a Lasting Impact on Health Through Lifestyle Modification

Three cardiologists, including the 2015-2016 president of the American College of Cardiology, review the evidence in support of lifestyle modification for diabetes management or remission.


Deborah Morosini, MD

Latest:

Recommendations for the Role of Clinical Pathways in an Era of Personalized Medicine

We offer recommendations for the development and design of clinical pathways in an effort to establish a set of normative criteria that creates trust and transparency.


John Hornberger, MD, MS, FACP

Latest:

Cost-Effectiveness of Combinatorial Pharmacogenomic Testing for Treatment-Resistant Major Depressive Disorder Patients

Using a state-transition probability analysis, this study assessed the long-term outcomes and economic implications of combinatorial pharmacogenomic testing for managing patients with major depressive disorder who were nonresponsive to treatments.


Truman J. Milling Jr, MD

Latest:

Exploring Indications for the Use of Direct Oral Anticoagulants and the Associated Risks of Major Bleeding

This supplement to The American Journal of Managed Care® describes the burden of thrombosis in terms of strokes and venous thromboembolism and highlights indications for the use of direct oral anticoagulants (DOACs) for the treatment of these conditions. The burden of DOAC-associated bleeding and unmet needs regarding reversal agents are also discussed.





John J. Whitman, MBA

Latest:

Impact of After-Hours Telemedicine on Hospitalizations in a Skilled Nursing Facility

A case study highlighting clinical and financial outcomes of an after-hours on-demand telemedicine intervention in a skilled nursing facility.


Pracha Eamranond, MD, MPH

Latest:

Improvement of Outpatient Quality Metrics in a Limited-Resource Setting

This study presents an example of a population health initiative in a limited-resource primary care setting that led to significant improvements in preventive care quality metrics in the context of major insurance payers.


Oyebode Taiwo, MBBS, MPH

Latest:

Process of Care Compliance Is Associated With Fewer Diabetes Complications

Adherence to process of care measures was associated with reduced risk of 2 diabetes complications or any of 4 complications in a national industrial cohort.


Morey Menacker, DO

Latest:

Case Study: How Does an ACO Generate Savings Three Years in a Row?

Increasing accountable care organization savings is dependent on maximizing quality scores and increasing the number of beneficiaries while maintaining a low per-capita spend through efficiencies of care.


Daniel M. Walker, PhD, MPH

Latest:

Approaches for Overcoming Barriers to Cross-Sector Data Sharing

The authors identified challenges to cross-sector data sharing and the approaches used to overcome these challenges in the Mid-Ohio Farmacy, a partnership to address food insecurity.


Michael H. Tran, PharmD, BCPS

Latest:

New Start Versus Continuing Users on Aripiprazole: Implications for Policy

New starts on aripiprazole were less adherent than continuing users. Prescriptions for 90-day supplies should be reserved for patients who have established effectiveness and tolerance.


Lisa A. Prosser, PhD

Latest:

Importance of Reasons for Stocking Adult Vaccines

Economic factors associated with the purchase and maintenance of vaccine inventory and inadequate reimbursement for vaccination services were the most important to pharmacy and doctors’ office decision makers when considering whether to stock adult vaccines.


Kelly Stolzmann, MS

Latest:

Deprescribing in the Context of Multiple Providers: Understanding Patient Preferences

Deprescribing could reduce the risk of harm from inappropriate medications. Understanding patient attitudes regarding which clinicians can make deprescribing recommendations can facilitate effective design and implementation of interventions.


Alexa R. Hospodar, BS

Latest:

Pricing of Monoclonal Antibody Therapies: Higher If Used for Cancer?

The annual price of monoclonal antibody therapies used in oncology and hematology is about $100,000 higher than those used in other disease states.


AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo